The Therapeutic Potential of Psychedelics: The European Regulatory Perspective

Written By Guest User

Representatives from the European Medicines Agency, national experts from the European medicines regulatory network, and the European College of Neuropsychopharmacology co-authored a joint commentary in the Lancet: "The Therapeutic Potential of Psychedelics: The European Regulatory Perspective".

Guest User
Previous

Europe needs to catch up with psychedelic research
Next

Australia becomes the first country to introduce psychedelic novel therapies to its medical healthcare